Pharmacovigilance 2024: Mastering Benefit-Risk Excellence Masterclass, Online 15-16 May 2024
Welcome to the “Benefit-Risk Assessment in Pharmacovigilance MasterClass 2024,”
A comprehensive two-day training designed to provide in-depth insights into the latest trends and methodologies shaping benefit-risk assessment within the pharmaceutical industry. This masterclass aims to equip participants with the essential knowledge and practical skills needed to navigate the complexities of benefit-risk evaluation throughout the lifecycle of medicinal products.
By participating in this masterclass, attendees will gain a thorough understanding of benefit-risk frameworks, methodologies, and regulatory expectations. The training offers a unique opportunity to enhance proficiency in performing hands-on benefit-risk analyses, ensuring participants are well-prepared to critically evaluate results and make informed decisions. Whether you are involved in drug safety, pharmacovigilance, regulatory affairs, or clinical research, this masterclass will empower you to optimize
WHO SHOULD ATTEND:
● Drug safety and pharmacovigilance professionals
● Safety evaluation experts
● Professionals involved in periodic safety reporting
● Experts in risk management planning and development of formal Risk Management Plans/REMS
● Medical writers.
● Regulatory strategy and regulatory affairs professionals.
● Clinical research experts.
● Medical Affairs professionals.